Sharemaestro Newsreel

West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at Zacks Research

Zacks Research downgraded West Pharmaceutical Services (NYSE:WST) from "strong buy" to "hold" despite the company reporting strong quarterly results, exceeding EPS and revenue estimates. The broader analyst consensus remains a "Moderate Buy" with an average price target of $368.08. West Pharmaceutical Services posted Q2 …

Smith+Nephew (SNN) lifts H1 2026 profit but cuts revenue growth outlook

Smith+Nephew reported a higher profit for the first half of 2026, with revenue reaching $3,097 million, an increase of 4.6% year-on-year, and trading profit up 8.1% to $566 million. Despite this profit growth, the company revised its full-year underlying revenue growth guidance downwards from …

Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses

Parnassus Investments, an investment management company, released the "Parnassus Core Equity Fund" second quarter of 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 16.83% in the second quarter of 2026, outperforming the S&P 500's 15.20% gain. Performance …

Smith & Nephew SNATS, Inc. $SNN Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 12.5% in the first quarter, selling 176,622 shares but still retaining over 1.2 million shares valued at approximately $39.4 million. Despite this sale, several other institutional investors increased …

CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update

CapsoVision, Inc. has released its Q2 2026 financial results, highlighting significant inventory growth, increased total assets, and a decrease in cash and cash equivalents. The medical device firm, classified as a non-accelerated filer, reported 50,046,913 shares outstanding and provided forward-looking statements regarding its operations …

Can Stryker (SYK) Still Look Undervalued After Backlog Recovery?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stryker stock has delivered a 35.9% gain over the past five years, yet current checks suggest it is not an obvious bargain, even as …

iRhythm (IRTC) Q2 2026 Earnings Call Transcript

GE HealthCare Technologies (GEHC) Stock Still Looks Cheap After A 20% Jump

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. GE HealthCare Technologies stock has climbed 19.7% over the past month, yet its valuation checks still lean toward the shares looking cheap rather …

Artivion (AORT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer - Pat MackinExecutive Vice President, Chief Operating Officer and Chief Financial Officer - Lance Berry TAKEAWAYS Revenue -- $125.8 million, up 9% …

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

Earnings Call Insights: CapsoVision, Inc. (CV) Q2 2026 MANAGEMENT VIEW * “The second quarter represented another period of steady progress for CapsoVision as we continued executing our commercial strategy while advancing several important initiatives across our product portfolio,” said (Co-Founder, President, CEO & Director …

Philips (ENXTAM:PHIA) Expands Open Monitoring Ecosystem And Launches Postpartum Support Tool

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Koninklijke Philips (ENXTAM:PHIA) announces new collaborations to expand its open monitoring ecosystem and connected …

Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?

When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioprocessing unit missed expectations, signaling continued softness in broader biopharma …

Cytosorbents (CTSO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Phillip ChanExecutive Vice President and Chief Financial Officer - Peter MarianiChief Medical Officer - Efthymios Deliargyris TAKEAWAYS Revenue -- $9.6 million, remaining consistent with …

CAPSOVISION ($CV) Releases Q2 2026 Earnings

Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?

Two ophthalmic technology leaders, Alcon Inc. (NYSE:ALC) and RxSight, Inc. (NASDAQ:RXST), earlier on July 6 entered into a strategic collaboration that highlights the evolving landscape of cataract and refractive surgery. The companies announced a non-exclusive pact to co-develop post-operatively adjustable pseudophakic intraocular lenses (PCIOLs). …

SANUWAVE (SNWV) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Morgan FrankChief Financial Officer - Peter Sorensen TAKEAWAYS Revenue -- $9.7 million, a 3% decrease from $10.1 million, reflecting a sharp decline …

Dexcom (DXCM) director Augustinos donates 1,075 shares and reports 5,575 RSUs

Dexcom director Nicholas Augustinos reported a gift of 1,075 shares of common stock to a charitable donor-advised fund on August 12, 2026. These shares were held indirectly through the Kirschner/Augustinos Revocable Trust, which now holds 37,382 shares. Additionally, Augustinos holds 5,575 unvested restricted stock …

PODD DEADLINE: SueWallSt Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline

SueWallSt is reminding investors of Insulet Corporation (NASDAQ: PODD) about an upcoming securities class action deadline on August 31, 2026. The lawsuit focuses on alleged defective cannula manufacturing that led to insulin under-delivery in millions of Omnipod devices and caused a significant decline in …

Co-Diagnostics outlines FDA dual 510(k) and CLIA waiver submission as cash falls to $3.6M

Earnings Call Insights: Co-Diagnostics (CODX) Q2 2026 MANAGEMENT VIEW * Dwight Egan (Chairman, CEO & President) framed Q2 as “another important step in our transition from platform development toward commercialization,” emphasizing “advancing regulatory milestones, expanding our global commercial opportunities, enhancing our platform capabilities and …

DexCom Inc (MIL:1DXCM) Stock Price, Trades & News

This page provides a detailed overview of DexCom Inc (MIL:1DXCM) stock, including its current price, market capitalization, P/E and P/B ratios, and key financial metrics. It highlights the company's financial strength, growth rank, profitability, and GF Value rank, along with recent news and upcoming …

Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and its officers, alleging violations of federal securities laws. The lawsuit claims that Insulet made materially false and misleading statements about its manufacturing controls and procedures, creating a …

CapsoVision Files Mixed Shelf for Up to $250 Million in Securities

CapsoVision, Inc. has filed a mixed shelf registration for up to $250 million in securities, as reported on August 13, 2026. This financial move allows the company flexibility in raising capital through various securities offerings in the future. The announcement coincides with other recent …

CapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.02, revenue of $3.64M misses by $0.17M

* CapsoVision, Inc. press release [https://seekingalpha.com/pr/20619065-capsovision-reports-second-quarter-2026-financial-results] (CV [https://seekingalpha.com/symbol/CV]): Q2 GAAP EPS of -$0.15 misses by $0.02. * Revenue of $3.64M (+9.6% Y/Y) misses by $0.17M. MORE ON CAPSOVISION, INC. * Seeking Alpha’s Quant Rating on CapsoVision, Inc. [https://seekingalpha.com/symbol/CV/ratings/quant-ratings] * Historical earnings data for CapsoVision, …

GE HealthCare Technologies Inc. stock rises Thursday, outperforms market

GE HealthCare Technologies Inc. (GEHC) stock rose 2.09% on Thursday, closing at $73.79. This performance outpaced the broader market, with the S&P 500 Index gaining 0.65% and the Dow Jones Industrial Average rising 0.13%. The increase broke a two-day losing streak for the company's …

Zimmer Biomet (ZBH) sees Dodge & Cox disclose 12.5% ownership stake

Dodge & Cox has filed an amended Schedule 13G, revealing a 12.5% beneficial ownership stake in Zimmer Biomet Holdings, Inc. (ZBH), as of June 30, 2026. This represents 24,124,735 shares, with Dodge & Cox holding sole voting power over 22,808,935 shares and sole dispositive …

Co-Diagnostics (CODX) posts Q2 loss and flags going concern, raises new equity

Co-Diagnostics (CODX) reported significant losses and minimal revenue for Q2 2026, leading management to flag substantial doubt about its ability to continue as a going concern without additional capital. The company posted a net loss of $6.3 million for the quarter and $15.4 million …

CapsoVision (CV) widens losses in H1 2026 and flags going concern risk

CapsoVision (CV) reported widened losses in the first half of 2026, with a net loss of $14.51 million and cash and cash equivalents of $9.08 million against $14.47 million used in operating activities. Despite raising $14 million in a March 2026 private placement and …

Mobia Medical (MOBI) investors report up to 11.6% ownership in Schedule 13G

U.S. Venture Partners XII, L.P., Presidio Management Group XII, L.L.C., and Casey M. Tansey have filed a Schedule 13G disclosing significant ownership stakes in Mobia Medical, Inc. (MOBI). U.S. Venture Partners XII, L.P. holds 5.7%, Presidio Management Group XII, L.L.C. holds 10.9%, and Casey …

Bleichroeder discloses 9.99% SINTX Technologies (SINT) stake with warrant limits

Bleichroeder LP and related entities have disclosed a 9.99% beneficial ownership stake in SINTX Technologies Inc. (SINT) via a Schedule 13G filing. This stake, totaling 647,513 common shares, includes both currently held shares and shares issuable upon the exercise of warrants, which are subject …

Quantum-Si GAAP EPS of -$0.11 beats by $0.01, revenue of $0.34M beats by $0.04M

* Quantum-Si press release [https://seekingalpha.com/pr/20619102-quantum-si-reports-second-quarter-2026-financial-results-and-provides-proteus-development] (QSI [https://seekingalpha.com/symbol/QSI]): Q2 GAAP EPS of -$0.11 beats by $0.01. * Revenue of $0.34M (-42.4% Y/Y) beats by $0.04M. * For the full year 2026, the Company reiterated the following financial guidance, as initially issued on March 3, 2026: …

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting revenue of $0.17 million and a net loss of $6.3 million. The company highlighted significant operational progress, including advancing manufacturing in Saudi Arabia, expanding commercial outreach in Europe and …

CapsoVision Reports Second Quarter 2026 Financial Results

CapsoVision reported second-quarter 2026 revenue of $3.6 million, a 10% increase year-over-year, driven by a 13% rise in CapsoCam Plus capsule sales. The company launched its AI Highlights™ feature internationally and anticipates FDA clearance for the U.S. market by the end of Q3 2026, …

LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares

LivaNova PLC's Chief Innovation Officer, Ahmet Tezel, exercised 12,692 Stock Appreciation Rights (SARs) at a base price of $52.68 per share. Concurrently, 8,589 shares were withheld to cover the SARs base price, 1,428 shares for tax liability, and 2,675 shares were sold on the …